MICHAEL SEBEK: Open Payments
NPI 1841249653 · NEBRASKA CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 11 payments from 6 companies in 2025. Trend: 2023 $251 · 2024 $298 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $53 |
| ABBVIE INC. | 3 | $48 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, VRAYLAR, VYNDAMAX, XIFAXAN, UBRELVY, MOUNJARO, VOQUEZNA, Rybelsus.
Industry payments across NE — which companies pay providers there.
